Business Development Sr. Financial Analyst, Clinical Licensing

logo

Business Development Sr. Financial Analyst, Clinical Licensing

Quest Diagnostics

icon Memphis, TN, US, 38141

iconFull Time

icon10 July 2024

Job Expired

The Business Development Sr. Financial Analyst (“SFA”), Clinical Licensing is responsible for generating business and financial analysis for the purpose of supporting the Corporate Business Development team in their evaluation and execution of strategic investments, collaborations, and licensing transactions. The SFA is responsible for preparing financial models and deal analysis and generating business case under the direction of senior members of the team. The SFA will be able to work independently to complete research and evaluation of potential deals while also providing organizational support within a team environment. This individual will prepare valuation analysis in Excel and C-Suite level business cases in PowerPoint, support due diligence, and be leveraged in the negotiation process.


  • Supports strengthening overall quality of deal flow and equity investments spawning from Quest and that align with Quest’s strategic interest
  • Supports Corporate Business Development strategic initiatives through the researching and monitoring of markets and companies
  • Responsible for preparing financial analyses and valuation models to screen and evaluate licensing and investment opportunities
  • Preparation of company profiles and presentations on proposed licensing transactions, strategic investments, and alliances for senior management review
  • Assists with sourcing and identification of innovation opportunities and monitoring venture landscape for disruptive business models and healthcare solutions
  • Assists with investment management activities and supports due diligence on equity transactions including organizing and coordination of the deal team activities.  Has direct interaction with Bankers, Venture Capital firms, and strategic partners through the deal execution process
  • Collaborates with cross-functional teams across the organization on the deal execution and execution planning of key transactions
  • Maintains BD pipeline and Strategic Investment database, develops Quarterly BD Pipeline Report and Strategic investment reports that are used to organize the Business Development group’s activities and to communicate with senior management
  • Bachelor’s degree in a scientific or business field is required; MBA/MS preferred
  • Minimum 1-3 years work experience in finance, investment banking, venture capital/private equity or related corporate finance function. Related industry experience and/or M&A experience preferred
  • Experience building financial models and analyzing financial statements
  • Prior experience in analyzing companies across a wide range of industry subspecialties including lab services, healthcare information technology, insurance, clinical trials, and molecular diagnostics / in-vitro diagnostics
  • Research skills and experience using web-based screening tools
  • Experience working with different teams and functional areas in a highly “matrixed” corporate organization
  • Demonstrated success in influencing and collaborating across many functions and levels
  • Demonstrated ability to think strategically, and develop strategic insights about industry drivers, clinical trends and competitive landscape to subsequently develop a corporate business development strategy
  • Proficiency in Microsoft Word, Excel and PowerPoint as well as Internet/Web applications
  • Healthcare industry knowledge preferred, but not required
  • Ability to juggle multiple projects simultaneously and to work well with different cross-functional teams within the organization
  • Excellent writing and communication skills

 
Competencies:

  • Business acumen
  • Drive for results
  • Organizational agility
  • Strategic Influencer
  • Positive attitude and good people skills
  • Resourcefulness and flexibility

Related Jobs

icon Memphis, TN, US

7 November 2024

icon Memphis, TN, US

7 November 2024

icon Memphis, TN, US

7 November 2024